4.7 Article

Development of cell-active non-peptidyl inhibitors of cysteine cathepsins

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 21, Issue 11, Pages 2975-2987

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2013.03.062

Keywords

Cysteine protease inhibitor; Cathepsin inhibitor; Sulfonyloxiranes; Cancer metastasis; Cell migration

Funding

  1. PSC-CUNY Research Award Program
  2. Queensborough Community College (QCC)/Queens College NSF-STEP
  3. NIH

Ask authors/readers for more resources

Cysteine cathepsins are an important class of enzymes that coordinate a variety of important cellular processes, and are implicated in various types of human diseases. However, small molecule inhibitors that are cell-permeable and non-peptidyl in nature are scarcely available. Herein the synthesis and development of sulfonyloxiranes as covalent inhibitors of cysteine cathepsins are reported. From a library of compounds, compound 5 is identified as a selective inhibitor of cysteine cathepsins. Live cell imaging and immunocytochemistry of metastatic human breast carcinoma MDA-MB-231 cells document the efficacy of compound 5 in inhibiting cysteine cathepsin activity in living cells. A cell-motility assay demonstrates that compound 5 is effective in mitigating the cell-migratory potential of highly metastatic breast carcinoma MDA-MB-231 cells. (C) 2013 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available